Renovos Attains FDA Breakthrough Device Designation for RENOVITE® BMP-2 16/01/2024 Emma Matrick Renovos, a pioneering biotechnology company, proudly announces its recent achievement of Breakthrough Device Designation from the US Food and Drug Administration (FDA) for its groundbreaking product, ... Read More
